Serca Pharmaceuticals

Private

OsloHealthcare & Life Scienceshttps://sercapharmaceuticals.com/

Last Round

Grant

Jan 1, 2025

Total Funding Raised

$3.71M

Company Overview

Serca Pharmaceuticals is a biopharmaceutical company developing a novel cardioprotective drug candidate, 13-M, for the treatment of acute myocardial infarction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalcardioprotective drugacute myocardial infarctionheart attack treatmentsmall molecule drugischemic reperfusion injurypercutaneous coronary interventionPCIdrug developmentcardiac therapybiotech startupclinical trialsheart failure preventiondrug licensingpre-clinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Serca Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Serca Pharmaceuticals comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Serca Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jan 1, 2025
Grant	Oct 1, 2020
VC Round	Jul 1, 2019

View all Funding Rounds

Serca Pharmaceuticals Investors

Notable investors and investment history

Serca Pharmaceuticals investors
Investor	Rounds
Inven2	VC Round
Sarsia	VC Round
The Research Council of Norway	Grant

View all Investors

Serca Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Serca Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Serca Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersOslo

Employee Range2

Year Founded2018

Last FundingJan 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.